Review
doi: 10.1111/j.1600-0404.1993.tb04256.x.
Side effects of long acting cholinesterase inhibitors
Affiliations
- PMID: 8128840
- DOI: 10.1111/j.1600-0404.1993.tb04256.x
Item in Clipboard
Review
Side effects of long acting cholinesterase inhibitors
Acta Neurol Scand Suppl.
1993.
Abstract
This paper reviews the side effects of the two long acting cholinesterase inhibitors tacrine and velnacrine. It will focus on tacrine which has been most studied. The two drugs are special as the dosage of them is guided mainly by side effects and not by therapeutic effects in contrast to most drugs used for psychiatric disorders.
Similar articles
-
No association between tacrine transaminitis and the glutathione transferase theta genotype in patients with Alzheimer's disease.Pharmacogenetics. 1998 Aug;8(4):353-5. Pharmacogenetics. 1998. PMID: 9731722 No abstract available.
-
Clinical trials with velnacrine: (PROPP) the physician reference of predicted probabilities--a statistical model for the estimation of hepatotoxicity risk with velnacrine maleate.Acta Neurol Scand Suppl. 1993;149:46-52. doi: 10.1111/j.1600-0404.1993.tb04255.x. Acta Neurol Scand Suppl. 1993. PMID: 8128839 Clinical Trial.
-
What have we learned from the THA trials to facilitate testing of new AChE inhibitors.Prog Brain Res. 1993;98:427-9. doi: 10.1016/s0079-6123(08)62428-0. Prog Brain Res. 1993. PMID: 8248532 Review. No abstract available.
-
Pharmacodynamic and early clinical studies with velnacrine.Acta Neurol Scand Suppl. 1993;149:26-8. doi: 10.1111/j.1600-0404.1993.tb04250.x. Acta Neurol Scand Suppl. 1993. PMID: 8128834 Review.
-
[Tacrine in Alzheimer's disease].Rev Neurol. 1997 Jul;25 Suppl 1:S70-2. Rev Neurol. 1997. PMID: 9280671 Review. Spanish. No abstract available.
Cited by
-
Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease.RSC Adv. 2021 Jan 28;11(10):5325-5334. doi: 10.1039/d1ra00049g. eCollection 2021 Jan 28. RSC Adv. 2021. PMID: 35423107 Free PMC article.
-
Advances in the pharmacotherapy of Alzheimer's disease.Eur Arch Psychiatry Clin Neurosci. 1994;244(5):261-71. doi: 10.1007/BF02190379. Eur Arch Psychiatry Clin Neurosci. 1994. PMID: 7893772 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
